845271-69-4Relevant academic research and scientific papers
Quinazoline analogs as receptor tyrosine kinase inhibitors
-
Page/Page column 13, (2008/06/13)
This invention provides quinazoline analogs of Formula I: where A is bonded to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is substituted by up to two independent R3 groups. The invention also includes methods of using compounds of Formula I as type I receptor tyrosine kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
